ATLAS60 Degrees Pharmaceuticals (SXTP) earnings date: Nov 12, 2026
60 Degrees Pharmaceuticals (SXTP) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026. Analysts expect EPS of -$0.73.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on SXTP
| Last price | $0.90 (-4.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±7.1% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the 60 Degrees Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
60 Degrees Pharmaceuticals reports on Nov 12, 2026. One email the day before, with ATLAS’s read on 60 Degrees Pharmaceuticals. You can switch it off at any time.
Alert me before SXTP reportsFree to start. Creating an account takes under a minute.
Notify me when 60 Degrees Pharmaceuticals reports
Track SXTP free Add 60 Degrees Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
SXTP earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.73 |
| Last report | Aug 14, 2026 · Beat |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | -57.6% |
| Average move around a report | ±8.0% (last 4) |
| Sector | Healthcare · Biotechnology |
60 Degrees Pharmaceuticals earnings history: last 4 reports
60 Degrees Pharmaceuticals last reported on Aug 14, 2026: EPS of -$0.86 against an estimate of -$0.89 (+3.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$0.89 | -$0.86 | +3.4% | Beat | -8.5% |
| Jul 15, 2026 | $1.52 | $1.64 | +7.9% | Beat | +4.1% |
| May 13, 2026 | $0.03 | $0.05 | +66.7% | Beat | -2.7% |
| Mar 30, 2026 | -$2.00 | -$8.17 | -308.5% | Miss | +16.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for SXTP
See the fair value, the probability range and the earnings history of 60 Degrees Pharmaceuticals on its ATLAS page.
60 Degrees Pharmaceuticals (SXTP) stock analysisPlans from €3.99 a month.
60 Degrees Pharmaceuticals earnings: frequently asked questions
When does 60 Degrees Pharmaceuticals (SXTP) report earnings?
60 Degrees Pharmaceuticals is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for SXTP?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.73 per share (USD). Estimates can change before the report.
How often does SXTP beat earnings estimates?
Of its last 4 reports with a recorded result, 60 Degrees Pharmaceuticals beat the EPS estimate 3 times; the average surprise was -57.6%. Past results do not predict the next one.
How much does SXTP move around earnings?
Over its last 4 reports the stock moved an average of 8.0% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did 60 Degrees Pharmaceuticals beat earnings estimates last quarter?
60 Degrees Pharmaceuticals last reported on Aug 14, 2026: EPS of -$0.86 against an estimate of -$0.89 (+3.4% surprise), a beat.
How much does SXTP usually move in a day?
On a normal trading day the ATLAS model puts SXTP’s one-day range at about ±7.1%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer